PSA values identify candidates for long-term ADT 2 Dec 2011 0 comments Prostate-specific antigen values can act as an early surrogate for prostate cancer-specific mortality, identifying patients most likely to benefit from long-term androgen suppression therapy,…
New evidence backs expansion of bowel cancer screening 2 Dec 2011 0 comments Cancer experts say new evidence backs the already persuasive case to extend bowel cancer screening program from one off tests to biennial screening.
Glucose, not insulin, linked to colorectal cancer risk 2 Dec 2011 0 comments A new analysis from the Women’s Health Initiative has suggested that colorectal cancer risk is associated with elevated fasting glucose levels, but not with hyperinsulinaemia.
Elderly missing out on chemotherapy 2 Dec 2011 0 comments Elderly patients with colorectal cancer are often "undertreated", with a patient’s age affecting an oncologist’s choice of treatment, an Australian study confirms.
US revokes breast cancer drug's licence 25 Nov 2011 0 comments US health officials have revoked the authorisation of bevacizumab for breast cancer treatment, saying the drug has "not been shown to be safe and effective for that use".
Information tool for early menopause 25 Nov 2011 0 comments Australian experts have come up with an information tool to 'fill a gap' in treating breast cancer in women with early menopause.
Touted benefits of pre-op MRI remain unproven 18 Nov 2011 0 comments There is little evidence that pre-operative MRI improves outcomes for breast cancer patients, according to a new systematic review.
Bone-metastases well treated with denosumab 18 Nov 2011 0 comments Denosumab's use is not yet supported in the prevention of bone metastases in prostate cancer, a prospective trial reported in the Lancet concludes.
Brain impairments linked to cancer and chemotherapy 18 Nov 2011 0 comments New research sheds light on why some breast cancer patients experience neurological impairments, with evidence certain areas of the brain are particularly vulnerable to chemotherapy.
Little advantage from stenting malignant colonic obstruction: Cochrane 18 Nov 2011 0 comments Colorectal stenting is an inherently appealing strategy to relieve acute obstructions in patients with colorectal cancer but is less successful than emergency surgery, a Cochrane review has concluded.
